Neha Luthar

709 total citations
6 papers, 525 citations indexed

About

Neha Luthar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Neha Luthar has authored 6 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Neha Luthar's work include HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Neha Luthar is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Neha Luthar collaborates with scholars based in United States and Germany. Neha Luthar's co-authors include Toni M. Brand, Deric L. Wheeler, Mari Iida, Megan M. Starr, Ravi Salgia, Kelsey L. Corrigan, Mahmoud Toulany, Parkash S. Gill, Andrew P. Stein and Randall J. Kimple and has published in prestigious journals such as Cancer Research, Molecular Cancer and Molecular Cancer Therapeutics.

In The Last Decade

Neha Luthar

6 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neha Luthar United States	6	292	236	139	124	75	6	525
Virna Cepero Italy	7	217 0.7×	355 1.5×	146 1.1×	114 0.9×	27 0.4×	7	638
Christopher Montemagno France	14	169 0.6×	196 0.8×	105 0.8×	59 0.5×	86 1.1×	31	453
David Surguladze United States	10	290 1.0×	212 0.9×	89 0.6×	146 1.2×	31 0.4×	21	531
Allen Saliganan United States	12	275 0.9×	263 1.1×	202 1.5×	74 0.6×	38 0.5×	14	605
Patricia Bukczynska Australia	13	170 0.6×	360 1.5×	119 0.9×	125 1.0×	29 0.4×	23	545
Roza Zandi Denmark	7	264 0.9×	324 1.4×	91 0.7×	37 0.3×	62 0.8×	9	540
J. Baselga Spain	10	399 1.4×	312 1.3×	139 1.0×	46 0.4×	98 1.3×	25	649
W. H. Miller United States	9	486 1.7×	283 1.2×	166 1.2×	100 0.8×	104 1.4×	17	723
Marzena Walkiewicz Australia	16	274 0.9×	241 1.0×	317 2.3×	102 0.8×	33 0.4×	31	674
Frank Tsai United States	14	278 1.0×	185 0.8×	97 0.7×	154 1.2×	41 0.5×	36	483

Countries citing papers authored by Neha Luthar

Since Specialization

Citations

This map shows the geographic impact of Neha Luthar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neha Luthar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neha Luthar more than expected).

Fields of papers citing papers by Neha Luthar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neha Luthar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neha Luthar. The network helps show where Neha Luthar may publish in the future.

Co-authorship network of co-authors of Neha Luthar

This figure shows the co-authorship network connecting the top 25 collaborators of Neha Luthar. A scholar is included among the top collaborators of Neha Luthar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neha Luthar. Neha Luthar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Brand, Toni M., Mari Iida, Andrew P. Stein, et al.. (2014). AXL Mediates Resistance to Cetuximab Therapy. Cancer Research. 74(18). 5152–5164. 150 indexed citations

2.

Brand, Toni M., Mari Iida, Emily Dunn, et al.. (2014). Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 13(5). 1356–1368. 40 indexed citations

3.

Iida, Mari, Toni M. Brand, Megan M. Starr, et al.. (2014). Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Molecular Cancer. 13(1). 242–242. 49 indexed citations

4.

Iida, Mari, Toni M. Brand, David A. Campbell, et al.. (2013). Targeting AKT with the allosteric AKT inhibitor MK-2206 in non-small cell lung cancer cells with acquired resistance to cetuximab. Cancer Biology & Therapy. 14(6). 481–491. 40 indexed citations

5.

Brand, Toni M., et al.. (2013). Nuclear EGFR as a molecular target in cancer. Radiotherapy and Oncology. 108(3). 370–377. 188 indexed citations

6.

Iida, Mari, Toni M. Brand, Megan M. Starr, et al.. (2013). Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab. Neoplasia. 15(10). 1196–1206. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact